Association of Admission Blood Urea Nitrogen With 90-Day and 1-Year Functional Outcomes After Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Retrospective Cohort Study
This single-center retrospective cohort study of 375 acute ischemic stroke patients treated with intravenous thrombolysis found that higher admission blood urea nitrogen levels are independently associated with poor functional outcomes at both 90 days and 1 year, although the predictive accuracy of models incorporating this biomarker requires external validation before clinical application.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, millions of people around the world suffer a stroke, a sudden interruption of blood flow to the brain that can leave them unable to walk, speak, or care for themselves. When a stroke is caused by a clot, doctors can sometimes dissolve that blockage using a powerful medication called intravenous thrombolysis. This treatment is a race against time, and while it can save lives and restore function, it does not work the same way for everyone. Some patients recover remarkably well, while others struggle with lasting disabilities despite receiving the same care. For doctors and families, knowing early on who is likely to recover and who might face a harder road is crucial for planning care and managing expectations. The challenge lies in finding clues that are available immediately when a patient arrives at the hospital, clues that go beyond the obvious severity of the stroke itself to reveal the body's overall condition.
A team of researchers at the Second Affiliated Hospital of Guangzhou Medical University set out to find one such clue. They focused on a routine blood test result that is often overlooked in the context of stroke recovery: the level of blood urea nitrogen. This substance is a waste product created when the body breaks down protein. It is normally filtered out of the blood by the kidneys and excreted in urine. Because its level depends on how well the kidneys are working, how much protein the body is breaking down, and how much fluid is circulating in the body, it acts as a broad signal of the body's internal state. The researchers wanted to see if the amount of this waste product in a patient's blood upon arrival could predict how well they would function months later. They looked specifically at patients who had received the standard clot-dissolving treatment for acute ischemic stroke, tracking their progress at three months and again at one year.
The study examined the medical records of 375 patients treated between 2018 and 2023. The team carefully reviewed data collected the moment these patients were admitted, including their age, the severity of their stroke symptoms, and a wide range of blood test results. They then followed up with these patients to see how they were doing at two specific milestones: 90 days and one year after the stroke. To measure recovery, they used a standard scale that rates a person's ability to live independently, ranging from no symptoms at all to death. A score of two or lower on this scale was considered a favorable outcome, meaning the person could live without significant help, while a higher score indicated a poor outcome with greater disability.
When the researchers analyzed the data, they found a clear pattern. Patients who had higher levels of blood urea nitrogen when they first arrived at the hospital were significantly more likely to have a poor functional outcome at both the three-month and one-year marks. This association held true even after the team accounted for other major factors known to influence recovery, such as the patient's age and how severe their stroke symptoms were at the start. In fact, the study identified three main factors that consistently predicted a difficult recovery: older age, more severe initial stroke symptoms, and higher admission levels of blood urea nitrogen. For the three-month mark, the researchers also found that a specific measure of platelet variation, known as platelet distribution width, was linked to the outcome, though this factor did not appear to be as important for the one-year prediction.
The researchers built statistical models to see how well these factors worked together to predict the future. They found that combining the information about age, stroke severity, and blood urea nitrogen created a much more accurate picture of a patient's likely recovery than looking at blood urea nitrogen alone. While the blood test by itself offered some insight, it was not strong enough to be used as a standalone crystal ball. Instead, it served as a valuable piece of a larger puzzle. The models suggested that when a patient arrives with high levels of this waste product, it signals that their body is under significant stress, perhaps due to dehydration, kidney strain, or a high rate of protein breakdown, all of which can make recovery from a brain injury more difficult.
It is important to understand what this study does and does not prove. The researchers did not find that high blood urea nitrogen causes the poor outcomes; rather, they found that it is a marker that travels alongside them. The study does not suggest that doctors should change the clot-dissolving treatment based on this number, nor does it claim that simply lowering the level of this substance will improve a patient's recovery. The findings are based on a single hospital in China, and the researchers explicitly state that their models need to be tested in other groups of people before they can be used to guide real-world medical decisions. The study also noted that while the blood test provided useful information, it was not a replacement for the standard assessment of how severe the stroke was or how old the patient was.
In the end, this research adds a new layer to our understanding of stroke recovery. It highlights that the body's overall physiological state, reflected in a simple, routine blood test, plays a significant role in how well a person bounces back from a stroke. For the medical team, a high level of blood urea nitrogen acts as an early warning sign, suggesting that the patient may need closer monitoring and more comprehensive support during their recovery. While the study does not offer a magic cure or a guaranteed prediction, it provides a clearer, more nuanced view of the risks patients face, helping to bridge the gap between the immediate treatment of a stroke and the long journey of recovery that follows.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.